The resumption of the Johnson & Johnson (J&J) vaccine programme awaits approval of its updated protocol by the SA Health Products Regulatory Authority (Sahpra) and a group of university research ethics committees before the stalled programme can restart.

“Once we have received the formal documentation, we will be able to critically evaluate it and turn it around very quickly,” said Prof Marc Blockman, chair of the human research ethics committee at the University of Cape Town’s faculty of health...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.